ArticlePDF Available

The relevance of theobromine for the beneficial effects of cocoa consumption

Frontiers
Frontiers in Pharmacology
Authors:

Abstract and Figures

Cocoa consumption began in America and in the mid sixteenth Century it quickly spread to Europe. Beyond being considered a pleasant habit due to its rich sweet lingering taste, chocolate was considered a good nutrient and even a medicine. Traditionally, health benefits of cocoa have been related with the high content of antioxidants of Theobroma cocoa beans. However, the direct psychoactive effect due to methylxanthines in cocoa is notable. Theobromine and caffeine, in the proportions found in cocoa, are responsible for the liking of the food/beverage. These compounds influence in a positive way our moods and our state of alertness. Theobromine, which is found in higher amounts than caffeine, seems to be behind several effects attributed to cocoa intake. The main mechanisms of action are inhibition of phosphodiesterases and blockade of adenosine receptors. Further mechanisms are being explored to better understand the health benefits associated to theobromine consumption. Unlike what happens in other mammals -pets- included, theobromine is safe for humans and has fewer unwanted effects than caffeine. Therefore, theobromine deserves attention as one of the most attractive molecules in cocoa.
This content is subject to copyright.
PERSPECTIVE ARTICLE
published: 20 February 2015
doi: 10.3389/fphar.2015.00030
The relevance of theobromine for the beneficial effects of
cocoa consumption
Eva Martínez-Pinilla1*, Ainhoa Oñatibia-Astibia2and Rafael Franco3
1Laboratory of Cell and Molecular Neuropharmacology, Department of Neuroscience, Center for Applied Medical Research, University of Navarra, Pamplona,
Navarra, Spain
2Official College of Pharmacists of Gipuzkoa, San Sebastián, Spain
3Molecular Neurobiology Laboratory, Department of Biochemistry and Molecular Biology, Faculty of Biology, University of Barcelona, Barcelona, Spain
Edited by:
Rabia Latif, University of Dammam,
Saudi Arabia
Reviewed by:
Leonardo Cavone, Università degli
studi di Firenze, Italy
Giovanna Cenini, Universität Bonn,
Germany
*Correspondence:
Eva Martínez-Pinilla, Laboratory of
Cell and Molecular
Neuropharmacology, Department of
Neuroscience, Center for Applied
Medical Research, University of
Navarra, Pio XII 55, 31008
Pamplona, Navarra, Spain
e-mail: martinezpinillaeva@
gmail.com
Cocoa consumption began in America and in the mid sixteenth Century it quickly spread
to Europe. Beyond being considered a pleasant habit due to its rich sweet lingering
taste, chocolate was considered a good nutrient and even a medicine. Traditionally, health
benefits of cocoa have been related with the high content of antioxidants of Theobroma
cocoa beans. However, the direct psychoactive effect due to methylxanthines in cocoa is
notable. Theobromine and caffeine, in the proportions found in cocoa, are responsible for
the liking of the food/beverage. These compounds influence in a positive way our moods
and our state of alertness. Theobromine, which is found in higher amounts than caffeine,
seems to be behind several effects attributed to cocoa intake. The main mechanisms of
action are inhibition of phosphodiesterases and blockade of adenosine receptors. Further
mechanisms are being explored to better understand the health benefits associated
to theobromine consumption. Unlike what happens in other mammals -pets- included,
theobromine is safe for humans and has fewer unwanted effects than caffeine. Therefore,
theobromine deserves attention as one of the most attractive molecules in cocoa.
Keywords: caffeine, theobromine, cocoa, adenosine receptor, neurological disease, receptor antagonist
INTRODUCTION
Caffeine present in coffee and in cola beverages is heavily con-
sumed worldwide. The reason of such high consumption relates
to its benefits for day-life activities. Caffeine actions in the central
nervous system (CNS) are fundamental to understand the interest
of the intake of caffeine-containing beverages. Beneficial actions
range from alertness to reducing the risk of neurodegenerative
diseases. Although the highest concentration of caffeine is present
in coffee, cocoa also contains this methylxanthine (Figure 1)
but at doses that probably are not enough to activate neu-
ral mechanisms. However, cocoa has elevated concentrations of
a structurally similar component, theobromine. The effects of
theobromine have been less studied than those of caffeine but
it is known that this molecule exerts some positive effects in
different human pathologies. The combination of caffeine and
theobromine in cocoa may have the expected methylxanthine-
derived benefits without the side effects reported for caffeine.
Interestingly, the main action mechanism of caffeine and theo-
bromine consists of blocking adenosine receptors and inhibiting
phosphodiesterases. The present paper takes data of novel studies
that point toward alternative modes of action of theobromine.
Further research is, however, required to fully understand the
health benefits of cocoa consumption.
THEOBROMINE AND CAFFEINE CONTENT IN COCOA
The physiological effects of cocoa components and theobromine
in particular, deserve to be closely scrutinized to better under-
stand the properties of cocoa consumption. The differences
between coffee and cocoa perceived by consumers are mainly due
to their most abundant molecules: caffeine in coffee and theo-
bromine in cocoa. Moreover, the high contents of carbohydrates
in cocoa products may be a further factor to consider.
Besides the cocoa proven psychoactive potential, caffeine and
theobromine content is in full or in part responsible for the liking
of this food. Human volunteers consuming a drink plus a capsule
containing the two compounds, in amounts equivalent to those
found in 50 g of dark chocolate (19 mg caffeine and 250 mg
theobromine), liked the drink more than when the pairing was
with a capsule containing placebo (Smit and Blackburn, 2005).
These results, probably mediated by adenosine receptors, are
conclusive of reinforcing actions of methylxanthines at doses and
proportions found in cocoa. It is important to note that neither
caffeine nor theobromine are addictive substances (see National
Institute on Drug Abuse, 2014) and also they are not in the list
of doping substances provided by the World Anti-Doping Agency
(see The World Anti-Doping Agency (WADA), 2014).
THEOBROMINE STUDIES IN MAMMALS: SAFETY AND
TOXICITY
In vivo effects of xenobiotic or synthetic drugs require the use
of animal models. However, theobromine, appears to be toxic
in some mammals, including pets (Smit, 2011). Laboratory ani-
mal toxicity is a factor to consider in the extrapolation of data
to humans. Reasons for this toxicity are not well established
www.frontiersin.org February 2015 | Volume 6 | Article 30 |1
Martínez-Pinilla et al. Theobromine and cocoa consumption
FIGURE 1 | Chemical structure of xanthine, caffeine, theobromine, and
adenosine.
but unequivocally suggest that the action mechanisms of theo-
bromine in humans may be different from those observed in other
mammals. Due to these facts, the molecular pharmacology of
theobromine, in particular its effect on adenosine receptors must
be revisited using human tissue samples and cells, or heterologous
systems expressing human proteins. The knowledge of adverse
effects in some animals has probably prompted a relatively high
number of clinical trials that prove that theobromine is not toxic
for humans (Pendleton et al., 2012, 2013; Baggott et al., 2013)
but has benefits in a variety of conditions (see below). It should
be noted that the link between cocoa consumption and risk of
preeclampsia in pregnant women, described previously, has not
been proven. However, recent systematic reviews suggest the ben-
efits of cocoa intake in the prevention of gestational hypertension
(Klebanoff et al., 2009; Mogollon et al., 2013).
CAFFEINE, THEOBROMINE, AND ADENOSINE RECEPTORS
The main pharmacological effects of caffeine, largely due to its
structural similarity to adenosine molecule (Figure 1), include
the inhibition of phosphodiesterases (enzymes that degrade the
second messenger, cAMP), the regulation of intracellular calcium
levels and the antagonism of adenosine receptors (Choi et al.,
1988; McPherson et al., 1991; Chen and Chern, 2011; Johnson
et al., 2012; Tazzeo et al., 2012). These primary actions result in
the well-described physiological effects of caffeine as stimulant
of CNS (Smit et al., 2004; Ciruela et al., 2006). Moreover, this
methylxanthine can also perform other peripheral processes such
as relax smooth muscles or stimulate the diuresis and cardiac
muscle contraction (Tazzeo et al., 2012). Caffeine is mainly
metabolized by the liver and, interestingly, one of its metabolites
is theobromine (Becker et al., 1984).
As methylxanthines, caffeine and theobromine (Figure 1),
are blockers of adenosine receptors which are G-protein-coupled
receptors that sense the presence of extracellular adenosine.
Adenosine is both an intermediate metabolite and also a messen-
ger molecule that exerts its hormone-like action in the periphery
and acts as a potent neuroregulator in the CNS. Four receptor
subtypes for the compound have been identified: A1, A2A, A2B,
and A3, widely distributed in the human body although with
differential cell/tissue expression. Brain physiology is dependent
upon variations in the concentration of adenosine that impacts
on adenosine receptors in neurons. In this sense, a quick way to
start the daily activities is disrupting the effect of adenosine in
the brain by using blockers of its specific receptors. Technically
such blockers are called “antagonists and, therefore, caffeine
and theobromine are antagonists of adenosine receptors. Grow-
ing evidence in the last decade indicates that theobromine has
psychoactive actions in humans that are qualitatively different
from those of caffeine (Mitchell et al., 2011; Baggott et al., 2013).
The effect of theobromine on blood pressure (van den Bogaard
et al., 2010) is also qualitatively different than that of caffeine
(Mitchell et al., 2011) but the reasons for these differences are not
established.
One possible explanation for the discrepancy in the effects of
caffeine and theobromine could be their different half-life. Half-
life of theobromine is higher than caffeine even in rodents, which
have a faster hepatic metabolism. Thus, half of the theobromine
administered to rats is excreted unchanged (Bonati et al., 1984).
The mean half-life in plasma from healthy volunteers is approxi-
mately 10 h and the percentage of unmodified compound present
in urine collected for 48 h after a single dose of 10 mg/Kg is
relatively high (16–18% depending on the technique for isolation
and quantitation; Tarka et al., 1983). The importance of this fact
is evidenced when methylxanthines are used as bronchodilators
in the management of asthma patients in whose serum the half-
life is also higher for theobromine than for caffeine (Becker et al.,
1984). When one of the main xenobiotic metabolizing enzymes,
cytochrome P450 1A2 (YP1A2), is expressed in heterologous cells
the rate of transformation is much lower for theobromine (5%)
than for caffeine (81%; Gu et al., 1992) thus confirming that
caffeine is more labile in terms of degradation than theobromine.
Effects of in vivo administration of caffeine are in part due to
the products of its metabolism. As relatively stable compound,
theobromine may play a crucial role in some beneficial effects
attributed to caffeine.
Theobromine is useful in asthma and in other respiratory
tract problems such as cough for which no definitive drug has
been developed. Codeine is very effective but its metabolism to
compounds acting on opioid receptors limits its use (Prieto-
Lastra et al., 2006). A safety and natural alternative could be
theobromine since it is able to prevent cough provoked by citric
acid in guinea-pigs and by capsaicin (an irritant component of
chili peppers) in humans. This double-blind placebo-controlled
study was complemented with in vitro studies using human
vagus nerve preparations in which theobromine inhibited the
depolarization effect of capsaicin (Usmani et al., 2005). Bearing
in mind these results, theobromine seems to suppress cough by
inhibiting the activation of afferent nerves. Two clinical trials
have been completed to test antitussive action of theobromine
but no results are available yet. In one of them (NCT01416480
Frontiers in Pharmacology | Experimental Pharmacology and Drug Discovery February 2015 | Volume 6 | Article 30 |2
Martínez-Pinilla et al. Theobromine and cocoa consumption
identifier in clinicaltrials.org) 300 mg of theobromine capsules
were used for antitussive effects in acute bronchitis. In a second
study (NCT01656668 identifier in clinicaltrials.org) capsules of
300 mg theobromine were evaluated in frequent long-term cough.
Whether cocoa consumption may be helpful to prevent coughing
or to diminish cough intensity remain to be determined.
Noteworthy, van Zyl et al. (2008) reported that the diffusion
of theobromine in lung substructures is higher than that of other
drugs used in the therapy of respiratory diseases. The authors sug-
gest that not only lipophilicity but also the position of alkyl groups
in the purine ring affect the ability of caffeine and theobromine to
cross biological membranes. The differential capability of tissue
penetration and accumulation may explain why theobromine
may achieve higher effects than caffeine. Although theobromine
may have less affinity for receptors than caffeine, the efficacy of
theobromine may become higher if it readily crosses membranes
and reaches high interstitial concentrations.
Benefits of the theobromine on cough seem to be related
with its anti-inflammatory potential as well as with modulation
of airway reactivity (Mokry et al., 2009). Non-selective phos-
phodiesterase inhibitors are already efficacious in suppression of
airway hyperreactivity. From the dozen existing enzymes cleaving
cyclic mononucleotides (cAMP/cGMP), phosphodiesterase four
is a good choice as therapeutic target in cough suppression
(Mokry and Nosalova, 2011). Cortijo et al. (1993) showed an
enrichment of phosphodiesterase four in human bronchial tissue
and a good correlation between enzyme inhibition and bron-
chorelaxation potency. Recently, Sugimoto et al. (1994, 2014)
have demonstrated that the antitumor potential effect of theo-
bromine in malignant glioblastoma proliferation results from
regulation of phosphodiesterase four, protein kinase B, extracel-
lular signal-regulated p38 mitogen-activated protein kinase and
nuclear factor-kappa B. Acting as phosphodiesterase inhibitors,
methylxanthines are able to downregulate pro-inflammatory
cytokines such as interferon-gamma or tumor necrosis factor-
alpha (Harris et al., 2010). Apart from a direct theobromine
effect on phosphodiesterases, the results are consistent with
blockade of adenosine receptors negatively affecting adenylate
cyclase activity, i.e., those coupled to Giproteins (A1and A3
receptors).
ADENOSINE RECEPTOR-INDEPENDENT EFFECTS OF
THEOBROMINE
Despite mainly acting as adenosine antagonist, theobromine may
have actions that are not mediated by the blockade of these
receptors. Theobromine and other main components of a hydro-
alcoholic guaraná extract are able to reduce cell toxicity caused by
nitric oxide generation (Bittencourt et al., 2013). It is unlikely that
reduction of oxidative stress, DNA damage and lipid peroxidation
in cells by the guaraná extract are mediated by blocking adenosine
receptors.
In recent years, theobromine is starting to be widely studied
to look for common and differential mechanisms with caffeine.
Theobromine and caffeine are methylxanthines that may form
non-covalent stacking complexes with ATP (Gattuso et al., 2011)
and affect cell metabolism and/or DNA and RNA structure
(Johnson et al., 2012). In fact, theobromine and caffeine are able
to bind to DNA at millimolar concentrations (Johnson et al.,
2012) and theobromine can also interact with RNA (Johnson
et al., 2003). However, the full physiological consequences of
these findings are not known yet. One hypothesis proposes that
sustained interaction with DNA and RNA after consumption of
methylxanthines in cocoa, might lead to induce or repress gene
expression. Oleaga et al. (2012) have shown that a polyphenolic
extract of cocoa alters the expression of genes in human breast
cancer cells. Accordingly, one attractive possibility is the impact
in the expression of genes with potential to decrease the risk of
neurodegenerative diseases. Recent reports indicated that chronic
consumption of coffee leads to reduced risk of Alzheimer’s and of
Parkinson’s disease (Maia and de Mendonça, 2002; Costa et al.,
2010; Eskelinen et al., 2011; Messerli, 2012). This beneficial effect
is totally linked to a continued consumption at mid life, i.e. intake
of methylxanthine-containing products reduces neurodegenera-
tion later in life (Pelligrino et al., 2010; Klaassen et al., 2013; Haller
et al., 2014).
The effect of theobromine in respiratory diseases is not due
to inhibition of mediators of inflammation in asthma, histamine
or slow reacting substance of anaphylaxis (Hillyard et al., 1984).
A novel differential target of methylxanthines is poly(ADP-
ribose)polymerase-1, a nuclear enzyme that is poorly inhibited by
caffeine but significantly inhibited by theobromine (Geraets et al.,
2006). In this sense, Ahmad et al. (2015) have recently shown
that inhibition of poly(ADP-ribose)polymerase-1 significantly
reduces inflammation of lungs caused by gamma-carrageenan.
Recent evidence demonstrates neovascularization in an animal
model of asthma (Wagner et al., 2015). Interestingly, theobromine
may reduce neovascularization accompanying tumor growth and
metastasis (Gil et al., 1993) and, therefore, it may reduce both
acute symptoms and angiogenesis in asthma.
Exposure to nitrogen mustards causes lung inflammation and
upregulation of oxidative stress proteins in macrophages. The
analog of theobromine, pentoxifylline, is effective in reducing
inflammation and increasing the number of macrophages with
wound repair anti-inflammatory properties (Sunil et al., 2014).
The concentration of adenosine at inflammation sites is notable
(Cronstein et al., 1999) and, consequently, it can activate adeno-
sine receptors present in lung cells and in macrophages. Blockade
of adenosine receptors and/or inhibition of phosphodiesterases
may underlie the phenotypic changes caused by methylxanthines
in macrophages activated after the mustard inhalation.
A pilot study was developed to test whether theobromine
was able to protect the enamel surface of human molars. The
results of this in vitro study showed that two different concen-
trations of theobromine were able to preserve the structure of
the teeth treated three days with acidic hydroxyl-ethyl-cellulose
for demineralization (Kargul et al., 2012). This protective effect
may not be due to adenosine receptors since they are not present
on enamel surfaces. Theobromine benefits at this level were
attained at relatively high concentrations. Actually, cocoa contains
carbohydrates that may be metabolized by bacteria in the mouth
and causing dental caries so caution may be taken to consider
cocoa intake as protector for teeth. Sugar-free cocoa alternative
could result in benefits to reduce caloric intake and preventing
dental caries.
www.frontiersin.org February 2015 | Volume 6 | Article 30 |3
Martínez-Pinilla et al. Theobromine and cocoa consumption
Other adenosine receptor-independent effect of theobromine
is demonstrated in cardiovascular protection by significant
increases in HDL cholesterol plasma levels and decreases in LDL
ones. Clinical trials have been undertaken in volunteers taking
cocoa to assess the effect of this substance on plasma lipoprotein
levels (Kris-Etherton et al., 1994; Mursu et al., 2004; Wang-
Polagruto et al., 2006; Baba et al., 2007; Mellor et al., 2010;
Khan et al., 2012). The results of the clinical trial NCT01481389
(clinicaltrials.org) suggest that theobromine but not flavonoids is
the responsible for the increase in HDL levels in individuals taking
cocoa products (Neufingerl et al., 2013). The mechanism of HDL-
increasing effect is probably multifactorial and non-necessarily
related to the blockade of adenosine receptors. Likely based on
a diuretic effect in dogs (Macnider, 1917), theobromine has been
considered useful for weight loss and it is supplemented to herbal
tea preparations (Khazan et al., 2014). However, there is neither
enough data to confirm weight-loss potential in humans nor the
putative underlying mechanism.
CONCLUSION
Over the last decades, a remarkable progress has allowed under-
standing some of the molecular mechanisms that are behind
the proved health benefits of cacao consumption in man. Apart
from the high content of antioxidants, solid evidence points to
methylxanthines as key players in the beneficial effects. Caffeine
has been classically considered with higher potential than other
methylxanthines. Recent studies have highlighted the potential of
theobromine, which may act as antitumoral, anti-inflammatory
or cardiovascular protector molecule without the undesirable side
effects described for caffeine. The main mechanisms of action of
theobromine are inhibition of phosphodiesterases and blockade
of adenosine receptors but, interestingly, it exhibits other impor-
tant adenosine receptor-independent effects as the reduction of
cellular oxidative stress or regulation of gene expression. In this
sense, theobromine could be considered a safe and natural alter-
native in the treatment of some human diseases and may serve as
lead compound for the development of novel drugs
REFERENCES
Ahmad, S. F., Zoheir, K. M., Ansari, M. A., Korashy, H. M., Bakheet, S. A., Ashour,
A. E., et al. (2015). The role of poly(ADP-ribose) polymerase-1 inhibitor in
carrageenan-induced lung inflammation in mice. Mol. Immunol. 63, 394–405.
doi: 10.1016/j.molimm.2014.09.009
Baba, S., Osakabe, N., Kato, Y., Natsume, M., Yasuda, A., Kido, T., et al. (2007).
Continuous intake of polyphenolic compounds containing cocoa powder
reduces LDL oxidative susceptibility and has beneficial effects on plasma HDL-
cholesterol concentrations in humans. Am. J. Clin. Nutr. 85, 709–717.
Baggott, M. J., Childs, E., Hart, A. B., De Bruin, E., Palmer, A. A., Wilkinson, J.
E., et al. (2013). Psychopharmacology of theobromine in healthy volunteers.
Psychopharmacology (Berl) 228, 109–118. doi: 10.1007/s00213-013-3021-0
Becker, A. B., Simons, K. J., Gillespie, C. A., and Simons, F. E. (1984). The
bronchodilator effects and pharmacokinetics of caffeine in asthma. N. Engl. J.
Med. 310, 743–746. doi: 10.1056/NEJM198403223101202
Bittencourt, L. S., Machado, D. C., Machado, M. M., Dos Santos, G. F. F., Algarve,
T. D., Marinowic, D. R., et al. (2013). The protective effects of guaraná extract
(Paullinia cupana) on fibroblast NIH-3T3 cells exposed to sodium nitroprus-
side. Food Chem. Toxicol. 53, 119–125. doi: 10.1016/j.fct.2012.11.041
Bonati, M., Latini, R., Sadurska, B., Riva, E., Galletti, F., Borzelleca, J. F., et al.
(1984). Kinetics and metabolism of theobromine in male rats. Toxicology 30,
327–341. doi: 10.1016/0300-483X(84)90143-4
Chen, J. F., and Chern, Y. (2011). Impacts of methylxanthines and adenosine
receptors on neurodegeneration: human and experimental studies. Handb. Exp.
Pharmacol. 200, 267–310. doi: 10.1007/978-3-642-13443-2_10
Choi, O. H., Shamim, M. T., Padgett, W. L., and Daly, J. W. (1988). Caffeine
and theophylline analogues: correlation of behavioral effects with activity as
adenosine receptor antagonists and as phosphodiesterase inhibitors. Life Sci. 43,
387–398. doi: 10.1016/0024-3205(88)90517-6
Ciruela, F., Casadó, V., Rodrigues, R. J., Luján, R., Burgueño, J., Canals, M.,
et al. (2006). Presynaptic control of striatal glutamatergic neurotransmission
by adenosine A1-A2A receptor heteromers. J. Neurosci. 26, 2080–2087. doi:
10.1523/JNEUROSCI.3574-05.2006
Cortijo, J., Bou, J., Beleta, J., Cardelús, I., Llenas, J., Morcillo, E., et al. (1993).
Investigation into the role of phosphodiesterase IV in bronchorelaxation,
including studies with human bronchus. Br. J. Pharmacol. 108, 562–568. doi:
10.1111/j.1476-5381.1993.tb12841.x
Costa, J., Lunet, N., Santos, C., Santos, J., and Vaz-Carneiro, A. (2010). Caf-
feine exposure and the risk of Parkinson’s disease: a systematic review and
meta-analysis of observational studies. J. Alzheimers. Dis. 20(Suppl. 1), S221–
S238. doi: 10.3233/JAD-2010-091525
Cronstein, B. N., Montesinos, M. C., and Weissmann, G. (1999). Salicylates
and sulfasalazine, but not glucocorticoids, inhibit leukocyte accumulation
by an adenosine-dependent mechanism that is independent of inhibition of
prostaglandin synthesis and p105 of NFkappaB. Proc. Natl. Acad. Sci. U.S.A. 96,
6377–6381. doi: 10.1073/pnas.96.11.6377
Eskelinen, M. H., Ngandu, T., Tuomilehto, J., Soininen, H., and Kivipelto, M.
(2011). Midlife healthy-diet index and late-life dementia and Alzheimer’s dis-
ease. Dement. Geriatr. Cogn. Dis. Extra 1, 103–112. doi: 10.1159/000327518
Gattuso, G., Manfredib, G., and Sammartanob, S. (2011). Quantitative study on
the non-covalent interactions between ATP and caffeine, theophylline and
theobromine in aqueous solution. Fluid Phase Equilibria. 308, 47–54. doi:
10.1016/j.fluid.2011.06.006
Geraets, L., Moonen, H. J., Wouters, E. F., Bast, A., and Hageman, G. J. (2006). The
role of poly(ADP-ribose) polymerase-1 inhibitor in carrageenan-induced lung
inflammation in mice. Caffeine metabolites are inhibitors of the nuclear enzyme
poly(ADP-ribose)polymerase-1 at physiological concentrations. Biochem. Phar-
macol. 72, 902–910. doi: 10.1016/j.bcp.2006.06.023
Gil, M., Skopi ´
nska-Rózewska, E., Radomska, D., Demkow, U., Skurzak, H.,
Rochowska, M., et al. (1993). Effect of purinergic receptor antagonists suramin
and theobromine on tumor-induced angiogenesis in BALB/c mice. Folia Biol.
(Praha) 39, 63–68
Gu, L., Gonzalez, F. J., Kalow, W., and Tang, B. K. (1992). Biotransformation of caf-
feine, paraxanthine, theobromine and theophylline by cDNA-expressed human
CYP1A2 and CYP2E1. Pharmacogenetics 2, 73–77. doi: 10.1097/00008571-
199204000-00004
Haller,S., Montandon, M. L., Rodriguez, C., Moser, D.,Toma,S., Hofmeister, J., et al.
(2014). Acute caffeine administration effect on brain activation patterns in mild
cognitive impairment. J. Alzheimers. Dis. 41, 101–112. doi: 10.3233/JAD-132360
Harris, E., Schulzke, S. M., and Patole, S. K. (2010). Pentoxifylline in preterm
neonates: a systematic review. Paediatr. Drugs 12, 301–311. doi: 10.2165/
11532600-000000000-00000
Hillyard, P. A., Nials, A. T., Skidmore, I. F., and Vardey, C. J. (1984). Characteriza-
tion of the adenosine receptor responsible for the inhibition of histamine and
SRS-A release from human lung fragments. Br. J. Pharmacol. 83, 337–345. doi:
10.1111/j.1476-5381.1984.tb16493.x
Johnson, I. M., Kumar, S. G., and Malathi, R. (2003). RNA binding efficacy of
theophylline, theobromine and caffeine. J. Biomol. Struct. Dyn. 20, 687–692. doi:
10.1080/07391102.2003.10506885
Johnson, I. M., Prakash, H., Prathiba, J., Raghunathan, R., and Malathi, R. (2012).
Spectral analysis of naturally occurring methylxanthines (theophylline, theo-
bromine, and caffeine) binding with DNA. PLoS ONE 7:e50019–e50019. doi:
10.1371/journal.pone.0050019
Kargul, B., Özcan, M., Peker, S., Nakamoto, T., Simmons, W. B., and Falster, A. U.
(2012). Evaluation of human enamel surfaces treated with theobromine: a pilot
study. Oral Health Prev. Dent. 10, 275–282. doi: 10.3290/j.ohpd.a28524
Khan, N., Monagas, M., Andres-Lacueva, C., Casas, R., Urpí-Sardà, M., Lamuela-
Raventós, R. M., et al. (2012). Regular consumption of cocoa powder with milk
increases HDL cholesterol and reduces oxidized LDL levels in subjects at high-
risk of cardiovascular disease. Nutr. Metab. Cardiovasc. Dis. 22, 1046–1053. doi:
10.1016/j.numecd.2011.02.001
Frontiers in Pharmacology | Experimental Pharmacology and Drug Discovery February 2015 | Volume 6 | Article 30 |4
Martínez-Pinilla et al. Theobromine and cocoa consumption
Khazan, M., Hedayati, M., Kobarfard, F., Askari, S., and Azizi, F. (2014). Iden-
tification and determination of synthetic pharmaceuticals as adulterants in
eight common herbal weight loss supplements. Iran. Red Crescent Med. J. 16:
e15344. doi: 10.5812/ircmj.15344
Klaassen, E. B., De Groot, R. H., Evers, E. A., Snel, J., Veerman, E. C., Ligtenberg,
A. J., et al. (2013). The effect of caffeine on working memory load-related
brain activation in middle-aged males. Neuropharmacology 64, 160–167. doi:
10.1016/j.neuropharm.2012.06.026
Klebanoff, M. A., Zhang, J., Zhang, C., and Levine, R. J. (2009). Maternal serum
theobromine and the development of preeclampsia. Epidemiology 20, 727–732.
doi: 10.1097/EDE.0b013e3181aba664
Kris-Etherton, P. M., Derr, J. A., Mustad, V. A., Seligson, F. H., and Pearson,
T. A. (1994). Effects of a milk chocolate bar per day substituted for a high-
carbohydrate snack in young men on an NCEP/AHA Step 1 Diet. Am. J. Clin.
Nutr. 60, 1037S–1042S.
Macnider, W. D. (1917). The efficiency of various diuretics in the acutely nephro-
pathic kidney, protected, and unprotected by sodium carbonate. II. J. Exp. Med.
26, 19–35. doi: 10.1084/jem.26.1.19
Maia, L., and de Mendonça, A. (2002). Does caffeine intake protect from
Alzheimer’s disease? Eur. J. Neurol. 9, 377–382. doi: 10.1046/j.1468-
1331.2002.00421.x
McPherson, P. S., Kim, Y. K., Valdivia, H., Knudson, C. M., Takekura, H., Franzini-
Armstrong, C., et al. (1991). The brain ryanodine receptor: a caffeine-sensitive
calcium release channel. Neuron 7, 17–25. doi: 10.1016/0896-6273(91)90070-G
Mellor, D. D., Sathyapalan, T., Kilpatrick, E. S., Beckett, S., and Atkin, S. L.
(2010). High-cocoa polyphenol-rich chocolate improves HDL cholesterol in
Type 2 diabetes patients. Diabet. Med. 27, 1318–1321. doi: 10.1111/j.1464-
5491.2010.03108.x
Messerli, F. H. (2012). Chocolate consumption, cognitive function, and Nobel
laureates. N. Engl. J. Med. 367, 1562–1564. doi: 10.1056/NEJMon1211064
Mitchell, E. S., Slettenaar, M., Vd Meer, N., Transler, C., Jans, L., Quadt, F.,
et al. (2011). Differential contributions of theobromine and caffeine on mood,
psychomotor performance and blood pressure. Physiol. Behav. 104, 816–822.
doi: 10.1016/j.physbeh.2011.07.027
Mokry, J., and Nosalova, G. (2011). The influence of the PDE inhibitors on cough
reflex in guinea pigs. Bratisl. Lek. Listy 112, 131–135.
Mokry, J., Nosalova, G., and Mokra, D. (2009). Influence of xanthine derivatives on
cough and airway reactivity in guinea pigs. J. Physiol. Pharmacol. 60, 87–91.
Mogollon, J. A., Boivin, C., Philippe, K., Turcotte, S., Lemieux, S., Blanchet, C., et al.
(2013). Consumption of chocolate in pregnant women and risk of preeclampsia:
a systematic review. Syst. Rev. 2, 114. doi: 10.1186/2046-4053-2-114
Mursu, J., Voutilainen, S., Nurmi, T., Rissanen, T. H., Virtanen, J. K., Kaikkonen, J.,
et al. (2004). Dark chocolate consumption increases HDL cholesterol concentra-
tion and chocolate fatty acids may inhibit lipid peroxidation in healthy humans.
Free Radic. Biol. Med. 37, 1351–1359. doi: 10.1016/j.freeradbiomed.2004.06.002
National Institute on Drug Abuse. (2014). Commonly Abused Drugs Chart.
Available at: http://www.drugabuse.gov/drugs-abuse/commonly-abused-drugs-
charts/commonly-abused-drugs-chart (accessed November 5, 2014).
Neufingerl, N., Zebregs, Y. E., Schuring, E. A., and Trautwein, E. A. (2013).
Effect of cocoa and theobromine consumption on serum HDL-cholesterol
concentrations: a randomized controlled trial. Am. J. Clin. Nutr. 97, 1201–1209.
doi: 10.3945/ajcn.112.047373
Oleaga, C., García, M., Solé, A., Ciudad, C. J., Izquierdo-Pulido, M., and Noé, V.
(2012). CYP1A1 is overexpressed upon incubation of breast cancer cells with a
polyphenolic cocoa extract. Eur. J. Nutr. 51, 465–476. doi: 10.1007/s00394-011-
0231-2
Pelligrino, D. A., Xu, H. L., and Vetri, F. (2010). Caffeine and the control of cerebral
hemodynamics. J. Alzheimers. Dis. 20(Suppl. 1), S51–S62. doi: 10.3233/JAD-
2010-091261
Pendleton, M., Brown, S., Thomas, C., and Odle, B. (2012). Potential toxicity of
caffeine when used as a dietary supplement for weight loss. J. Diet. Suppl. 9,
293–298. doi: 10.3109/19390211.2012.736460
Pendleton, M., Brown, S., Thomas, C. M., and Odle, B. (2013). Potential toxicity
of caffeine when used as a dietary supplement for weight loss. J. Diet. Suppl. 10,
1–5. doi: 10.3109/19390211.2012.758215
Prieto-Lastra, L., Iglesias-Cadarso, A., Reaño-Martos, M. M., Pérez-Pimiento, A.,
Rodríguez-Cabreros, M. I., and García-Cubero, A. (2006). Pharmacological
stimuli in asthma/urticaria. Allergol. Immunopathol. (Madr) 34, 224–227. doi:
10.1157/13094030
Smit, H. J. (2011). Theobromine and the pharmacology of cocoa. Handb. Exp.
Pharmacol. 200, 201–234. doi: 10.1007/978-3-642-13443-2_7
Smit, H. J., and Blackburn, R. J. (2005). Reinforcing effects of caffeine and
theobromine as found in chocolate. Psychopharmacology (Berl) 181, 101–106.
doi: 10.1007/s00213-005-2209-3
Smit, H. J., Gaffan, E. A., and Rogers, P. J. (2004). Methylxanthines are the psycho-
pharmacologically active constituents of chocolate. Psychopharmacology (Berl)
176, 412–419. doi: 10.1007/s00213-004-1898-3
Sugimoto, K., Simard, J., Haagensen, D. E., and Labrie, F. (1994). Inverse relation-
ships between cell proliferation and basal or androgen-stimulated apolipopro-
tein D secretion in LNCaP human prostate cancer cells. J. Steroid Biochem. Mol.
Biol. 51, 167–174. doi: 10.1016/0960-0760(94)90090-6
Sugimoto, N., Miwa, S., Hitomi, Y., Nakamura, H., Tsuchiya, H., and Yachie,
A. (2014). Theobromine, the primary methylxanthine found in Theobroma
cacao, prevents malignant glioblastoma proliferation by negatively regulating
phosphodiesterase-4, extracellular signal-regulated kinase, Akt/mammalian tar-
get of rapamycin kinase, and nuclear factor-kappa B. Nutr. Cancer 66, 419–423.
doi: 10.1080/01635581.2013.877497
Sunil, V. R., Vayas, K. N., Cervelli, J. A., Malaviya, R., Hall, L., Massa, C. B.,
et al. (2014). Pentoxifylline attenuates nitrogen mustard-induced acute lung
injury, oxidative stress and inflammation. Exp. Mol. Pathol. 97, 89–98. doi:
10.1016/j.yexmp.2014.05.009
Tarka, S. M., Arnaud, M. J., Dvorchik, B. H., and Vesell, E. S. (1983). Theobromine
kinetics and metabolic disposition. Clin. Pharmacol. Ther. 34, 546–555. doi:
10.1038/clpt.1983.212
Tazzeo, T., Bates, G., Roman, H. N., Lauzon, A. M., Khasnis, M. D., Eto, M., et al.
(2012). Caffeine relaxes smooth muscle through actin depolymerization. Am. J.
Physiol. Lung.Cell Mol. Physiol. 303, L334–L342.doi:10.1152/ajplung.00103.2012
The World Anti-Doping Agency (WADA). (2014). WADA Prohibited List. Avail-
able at: http://www.usada.org/substances/prohibited-list (accessed November
10, 2014).
Usmani, O. S., Belvisi, M. G., Patel, H. J., Crispino, N., Birrell, M. A., Korbonits, M.,
et al. (2005). Theobromine inhibits sensory nerve activation and cough. FASEB
J. 19, 231–233. doi: 10.1096/fj.04-1990fje
van den Bogaard, B., Draijer, R., Westerhof, B. E., Van Den Meiracker, A. H.,
Van Montfrans, G. A., and Van Den Born, B. J. (2010). Effects on peripheral
and central blood pressure of cocoa with natural or high-dose theobromine:
a randomized, double-blind crossover trial. Hypertension 56, 839–846. doi:
10.1161/HYPERTENSIONAHA.110.158139
van Zyl, J. M., Derendinger, B., Seifartm, H. I., and Van der Bijl, P. (2008).
Comparative diffusion of drugs through bronchial tissue. Int. J. Pharm. 357,
32–36. doi: 10.1016/j.ijpharm.2008.01.028
Wagner, E. M., Jenkins, J., Schmieder, A., Eldridge, L., Zhang, Q., Moldobaeva, A.,
et al. (2015). Angiogenesis and airway reactivity in asthmatic Brown Norway
rats. Angiogenesis 18, 1–11. doi: 10.1007/s10456-014-9441-6
Wang-Polagruto, J. F., Villablanca, A. C., Polagruto, J. A., Lee, L., Holt, R. R.,
Schrader, H. R., et al. (2006). Chronic consumption of flavanol-rich cocoa
improves endothelial function and decreases vascular cell adhesion molecule
in hypercholesterolemic postmenopausal women. J. Cardiovasc. Pharma-
col. 47(Suppl. 2), S177–S186; discussion S206–S179. doi: 10.1097/00005344-
200606001-00013
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be
construed as a potential conflict of interest.
Received: 14 November 2014; paper pending published: 01 December 2014; accepted:
03 February 2015; published online: 20 February 2015.
Citation: Martínez-Pinilla E, Oñatibia-Astibia A and Franco R (2015) The relevance
of theobromine for the beneficial effects of cocoa consumption. Front. Pharmacol. 6:30.
doi: 10.3389/fphar.2015.00030
This article was submitted to Experimental Pharmacology and Drug Discovery, a
section of the journal Frontiers in Pharmacology.
Copyright ©2015 Martínez-Pinilla, Oñatibia-Astibia and Franco. This is an open-
access article distributed under the terms of the Creative Commons Attribution License
(CC BY). The use, distribution or reproduction in other forums is permitted, provided
the original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution
or reproduction is permitted which does not comply with these terms.
www.frontiersin.org February 2015 | Volume 6 | Article 30 |5
... Theobromine is found in cocoa at high levels and was also present in our coffee fermentation. This compound has a pleasant flavor and is useful as an anti-inflammatory in asthma and other respiratory tract problems [95]. Some metabolite compounds from our study have been reported to have antioxidant and anti-inflammatory properties, including 3-O-Feruloylquinic acid, 15-deoxy-∆-12,14-PGJ2, and 4-Hydroxy-3-methoxycinnamaldehyde [96][97][98], while other metabolites found in our fermented coffee have been reported as essential nutrients for a wide range of critical functions in the human body, including adenosine for heart and brain function [99,100]. ...
... Theobromine is found in cocoa at high levels and was also present in our coffee fermentation. This compound has a pleasant flavor and is useful as an anti-inflammatory in asthma and other respiratory tract problems [95]. Some metabolite compounds from our study have been reported to have antioxidant and antiinflammatory properties, including 3-O-Feruloylquinic acid, 15-deoxy-Δ-12,14-PGJ2, and 4-Hydroxy-3-methoxycinnamaldehyde [96][97][98], while other metabolites found in our fermented coffee have been reported as essential nutrients for a wide range of critical functions in the human body, including adenosine for heart and brain function [99,100]. ...
Article
Full-text available
Coffee is a critical agricultural commodity and is used to produce premium beverages enjoyed by people worldwide. The microbiome of coffee beans has proven to be an essential tool that improves the flavor profile of coffee by creating aromatic flavor compounds through natural fermentation. This study investigated the natural microbial consortium during the wet process fermentation of coffee onsite in Thailand in order to identify the correlation between microbial diversity and biochemical characteristics including flavor, aroma, and metabolic attributes. Our study found 64 genera of bacteria and 59 genera of yeast/fungi present during the fermentation process. Group of microbes, mainly yeast and lactic acid bacteria, that predominated in the process were significantly correlated with preferable flavor and aroma compounds, including linalyl formate, linalool, cis-isoeugenol, trans-geraniol, and (-)-isopulegol. Some of the detected metabolites were found to be active compounds which could play a role in health.
... For example, recent studies have highlighted the potential of theobromine as a protective agent against cancer, inflammation and cardiovascular disease. 7,14 For caffeine, both healthy and harmful effects on several physiological systems have been described. 7,15 In any case, an interesting possibility is that some cocoa components may act synergistically or in interaction, so the combination of caffeine and theobromine in cocoa may have the expected methylxanthine-derived benefits without the side effects reported for caffeine. ...
... 7,15 In any case, an interesting possibility is that some cocoa components may act synergistically or in interaction, so the combination of caffeine and theobromine in cocoa may have the expected methylxanthine-derived benefits without the side effects reported for caffeine. 14,16 Therefore, it is not only relevant to study the properties of each of the cocoa components separately, but also important to study the effects of the whole natural product, which is highly present in the everyday diet of millions around the world. ...
Article
Full-text available
Cocoa is widely known for its health benefits, but its neurocognitive impact remains underexplored. This preclinical study aimed to investigate the effects of cocoa and cocoa polyphenols on hippocampal neuroplasticity,...
... Theobromine is a major alkaloid found in the cacao bean. (Martínez-Pinilla et al., 2015) 7-methylxanthine and 1-methylurate are purine components derived from the metabolism of methylxanthines (e.g., caffeine and theobromine). (Langenau et al., 2020; Further investigation is needed to identify the specific food sources related to these peptides. ...
Article
Full-text available
Introduction There is a lack of biomarkers of clinically important diets, such as the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet. Objectives Our study explored serum metabolites associated with adherence to the MIND diet. Methods In 3,908 Atherosclerosis Risk in Communities (ARIC) study participants, we calculated a modified MIND diet score based on a 66-item self-reported food frequency questionnaire (FFQ). The modified score did not include berries and olive oil, as these items were not assessed in the FFQ. We used multivariable linear regression models in 2 subgroups of ARIC study participants and meta-analyzed results using fixed effects regression to identify significant metabolites after Bonferroni correction. We also examined associations between these metabolites and food components of the modified MIND diet. C-statistics evaluated the prediction of high modified MIND diet adherence using significant metabolites beyond participant characteristics. Results Of 360 metabolites analyzed, 27 metabolites (15 positive, 12 negative) were significantly associated with the modified MIND diet score (lipids, n = 13; amino acids, n = 5; xenobiotics, n = 3; cofactors and vitamins, n = 3; carbohydrates n = 2; nucleotide n = 1). The top 4 metabolites that improved the prediction of high dietary adherence to the modified MIND diet were 7-methylxanthine, theobromine, docosahexaenoate (DHA), and 3-carboxy-4-methyl-5-propyl-2-furanpropanoate (CMPF). Conclusion Twenty-seven metabolomic markers were correlated with the modified MIND diet. The biomarkers, if further validated, could be useful to objectively assess adherence to the MIND diet.
... Main phenolics and alkaloids have been found in the CPH being catechin, quercetin, epicatechin, gallic acid, coumaric acid, protocatechuic acid, theobromine, and theophylline [16][17][18]. In which, alkaloid compounds have been used in prevention and treatment of many chronic diseases such as theobromine, which may act as antitumoral, anti-inflammatory or cardiovascular protector molecule [19], while theophylline is used to prevent and treat wheezing, shortness of breath, and chest tightness caused by asthma, chronic bronchitis, emphysema, and other lung diseases [20]. However, they are unstable when exposed to oxygen, UV light, high temperature, and humidity [21]. ...
Article
Full-text available
Cocoa pod husk (CPH) is a main by-product in cocoa processing industry and rich in alkaloids, which display some potent pharmacological properties such as stimulatory effects on the central nervous, gastrointestinal, cardiovascular, renal, and respiratory systems. This study aimed to utilize the CPH and various encapsulating materials (maltodextrin, gum Arabic, and chitosan) for production of microencapsulated powder rich in alkaloids. Physicochemical properties in terms of moisture content (MC), water activity (aw), water soluble index (WSI), density and morphology, bioactive compounds including total alkaloids content (TAC), total phenolics content (TPC), total flavonoids content (TFC) and total saponins content (TSC), as well as antioxidant activity comprising ABTS/DPPH radical scavenging capacity (ARSC/DRSC) and ferric/cupric reducing antioxidant capacity (FRAP/CUPRAC) of powder rich in alkaloids from the CPH extract with and without microencapsulation were then analyzed and compared. The results showed that the MC and aw of microencapsulated powders (4.78 to 5.88% and 0.46 to 0.51, respectively) were lower than those of powder without microencapsulation (9.64% and 0.54, respectively). Use of maltodextrin and gum Arabic (9:1 w/w) as the wall materials for microencapsulation of the CPH extract obtained the greatest levels of TPC, TFC, TSC, DRSC, FRAP and CUPRAC (14.91 mg GAE, 22.69 mg CE, 113.21 mg EE, 24.59, 2.92 and 92.68 mg TE per g dried sample, respectively), while use of 100% maltodextrin resulted in the maximum amounts of TAC and ARSC (646.96 mg AE/g dried sample and 36.27 mg TE/g dried sample, respectively). Based on the obtained results, the mixture of maltodextrin and gum Arabic (9:1 w/w) was recommended to microencapsulate the alkaloids-enriched CPH extract for potential application in the nutraceutical and functional food industries. Graphical Abstract
... Some experiments have observed an increase in blood glucose levels, in both healthy men and women, following theobromine consumption [107]. As another AR antagonist, theobromine likely increases circulating glucose levels in the same way as caffeine, inhibiting the metabolic pathways mediated by adenosine that are involved in glucose uptake [95,108]. ...
Article
Full-text available
The global prevalence of type 2 diabetes (T2D) is 10.5% among adults in the age range of 20–79 years. The primary marker of T2D is persistent fasting hyperglycemia, resulting from insulin resistance and β-cell dysfunction. Multiple factors can promote the development of T2D, including obesity, inflammation, and oxidative stress. In contrast, dietary choices have been shown to prevent the onset of T2D. Oatmeal, lean proteins, fruits, and non-starchy vegetables have all been reported to decrease the likelihood of T2D onset. One of the most widely consumed beverages in the world, coffee, has also demonstrated an impressive ability to reduce T2D risk. Coffee contains a diverse array of bioactive molecules. The antidiabetic effects of coffee-derived polyphenols have been thoroughly described and recently reviewed; however, several non-polyphenolic molecules are less prominent but still elicit potent physiological actions. This review summarizes the effects of select coffee-derived non-polyphenols on various aspects of T2D pathogenesis.
... Derivatives of this compound have been synthesized as drugs due to their significant pharmaceutical properties, such as anti-tumor, anti-inflammatory, or cardio-protective effects, without undesirable side effects. The primary modes of action of theobromine are blocking adenosine receptors and inhibiting phosphodiesterase [85]. ...
Article
Growth factors and their receptor tyrosine kinases play a central role in regulating vital cellular processes such as proliferation, differentiation, division, and cell survival, and they are closely associated with the development of various types of cancer, particularly in the context of angiogenesis. Although several small chemical compounds targeting tyrosine kinase receptors have been approved by the FDA for cancer treatment by inhibiting angiogenesis, there is still a need for more effective medications. in silico studies are now crucial tools for the design of new drugs, offering considerable advantages such as cost and time reduction. In this review, we examined recent in silico research carried out between 2022 and 2024, focusing on new drug candidates synthesized to fight cancer, in particular by targeting tyrosine kinase receptors involved in the process of angiogenesis.
Article
Full-text available
Obesity, characterized by chronic low-grade inflammation, is a significant health concern. Phytochemicals found in plants are being explored for therapeutic use, particularly in combating obesity. Among these, theobromine, commonly found in cocoa and chocolate, shows promise. Although not as extensively studied as caffeine, theobromine exhibits positive effects on human health. It improves lipid profiles, aids in asthma treatment, lowers blood pressure, regulates gut microbiota, reduces tumor formation, moderates blood glucose levels, and acts as a neuroprotective agent. Studies demonstrate its anti-obesity effects through mechanisms such as browning of white adipose tissue, activation of brown adipose tissue, anti-inflammatory properties, and reduction of oxidative stress. This study aims to suggest theobromine as a potential therapeutic agent against obesity-related complications.
Article
Full-text available
Expanded and aberrant bronchial vascularity, a prominent feature of the chronic asthmatic airway, might explain persistent airway wall edema and sustained leukocyte recruitment. Since it is well established that there are causal relationships between exposure to house dust mite (HDM) and the development of asthma, determining the effects of HDM in rats, mammals with a bronchial vasculature similar to humans, provides an opportunity to study the effects of bronchial angiogenesis on airway function directly. We studied rats exposed bi-weekly to HDM (Der p 1; 50 μg/challenge by intranasal aspiration, 1, 2, 3 weeks) and measured the time course of appearance of increased blood vessels within the airway wall. Results demonstrated that within 3 weeks of HDM exposure, the number of vessels counted within airway walls of bronchial airways (0.5-3 mm perimeter) increased significantly. These vascular changes were accompanied by increased airway responsiveness to methacholine. A shorter exposure regimen (2 weeks of bi-weekly exposure) was insufficient to cause a significant increase in functional vessels or reactivity. Yet, (19)F/(1)H MR imaging at 3T following αvβ3-targeted perfluorocarbon nanoparticle infusion revealed a significant increase in (19)F signal in rat airways after 2 weeks of bi-weekly HDM, suggesting earlier activation of the process of neovascularization. Although many antigen-induced mouse models exist, mice lack a bronchial vasculature and consequently lack the requisite human parallels to study bronchial edema. Overall, our results provide an important new model to study the impact of bronchial angiogenesis on chronic inflammation and airways hyperreactivity.
Article
Full-text available
BACKGROUND: Adulterated herbal weight loss products with containing undeclared synthetic drugs are common and responsible for many serious health damages. OBJECTIVES: The purpose of the study was to determine five synthetic adulterants in eight common herbal weight loss supplements, which are currently sold in Iran markets, to verify their presence in supplements, without mentioning on the labels. MATERIALS AND METHODS: Eight common herbal weight loss samples were obtained from the Iran pharmaceutical market after advertising in the Persian language on satellite channels and internet. Five pharmacological classes of drugs used for weight loss, namely sibutramine, phenolphthalein, phenytoin, bumetanide and rimonabant, were investigated and quantified by GC-MS for the first three and LC-MS for the last two medications. RESULTS: The most undeclared ingredients, which were illegally added include sibutramine, phenolphthalein, bumetanide, and phenytoin in the original super slim, herbaceous essence, super slim green lean, and fat loss, supplements, respectively. Rimonabant was not found. Caffeine, pseudoephedrine, theobromine and amfepramone were also found in the supplements using GC-MS assay. CONCLUSIONS: Adulterated synthetic substances were detected in the herbal weight loss products. Health care professionals should make people aware of the risks of taking herbal weight-loss supplements. KEYWORDS: Gas Chromatography-Mass Spectrometry, Herbal Medicine, United States Food and Drug Administration, Weight Loss
Article
Full-text available
Adulterated herbal weight loss products with containing undeclared synthetic drugs are common and responsible for many serious health damages. The purpose of the study was to determine five synthetic adulterants in eight common herbal weight loss supplements, which are currently sold in Iran markets, to verify their presence in supplements, without mentioning on the labels. Eight common herbal weight loss samples were obtained from the Iran pharmaceutical market after advertising in the Persian language on satellite channels and internet. Five pharmacological classes of drugs used for weight loss, namely sibutramine, phenolphthalein, phenytoin, bumetanide and rimonabant, were investigated and quantified by GC-MS for the first three and LC-MS for the last two medications. The most undeclared ingredients, which were illegally added include sibutramine, phenolphthalein, bumetanide, and phenytoin in the original super slim, herbaceous essence, super slim green lean, and fat loss, supplements, respectively. Rimonabant was not found. Caffeine, pseudoephedrine, theobromine and amfepramone were also found in the supplements using GC-MS assay. Adulterated synthetic substances were detected in the herbal weight loss products. Health care professionals should make people aware of the risks of taking herbal weight-loss supplements.
Article
Full-text available
Previous studies showed that acute caffeine administration enhances task-related brain activation in elderly individuals with preserved cognition. To explore the effects of this widely used agent on cognition and brain activation in early phases of cognitive decline, we performed a double-blinded, placebo-controlled functional magnetic resonance imaging (fMRI) study during an n-back working memory task in 17 individuals with mild cognitive impairment (MCI) compared to 17 age-matched healthy controls (HC). All individuals were regular caffeine consumers with an overnight abstinence and given 200 mg caffeine versus placebo tablets 30 minutes before testing. Analyses included assessment of task-related activation (general linear model), functional connectivity (tensorial-independent component analysis, TICA), baseline perfusion (arterial spin labeling, ASL), grey matter density (voxel-based morphometry, VBM), and white matter microstructure (tract-based spatial statistics, TBSS). Acute caffeine administration induced a focal activation of the prefrontal areas in HC with a more diffuse and posteromedial activation pattern in MCI individuals. In MCI, TICA documented a significant caffeine-related enhancement in the prefrontal cortex, supplementary motor area, ventral premotor and parietal cortex as well as the basal ganglia and cerebellum. The absence of significant group differences in baseline ASL perfusion patterns supports a neuronal rather than a purely vascular origin of these differences. The VBM and TBSS analyses excluded potentially confounding differences in grey matter density and white matter microstructure between MCI and HC. The present findings suggest a posterior displacement of working memory-related brain activation patterns after caffeine administration in MCI that may represent a compensatory mechanism to counterbalance a frontal lobe dysfunction.
Article
Full-text available
Theobromine, a caffeine derivative, is the primary methylxanthine produced by Theobroma cacao. We previously showed that methylxanthines, including caffeine and theophylline, have antitumor and antiinflammatory effects, which are in part mediated by their inhibition of phosphodiesterase (PDE). A member of the PDE family, PDE4, is widely expressed in and promotes the growth of glioblastoma, the most common type of brain tumor. The purpose of this study was to determine whether theobromine could exert growth inhibitory effects on U87-MG, a cell line derived from human malignant glioma. We show that theobromine treatment elevates intracellular cAMP levels and increases the activity of p38 mitogen-activated protein kinase and c-Jun N-terminal kinase, whereas it attenuates p44/42 extracellular signal-regulated kinase activity and the Akt/mammalian target of rapamycin kinase and nuclear factor-kappa B signal pathways. It also inhibits cell proliferation. These results suggest that foods and beverages containing cocoa bean extracts, including theobromine, might be extremely effective in preventing human glioblastoma.
Article
Full-text available
Previous studies have been limited in reporting the association between chocolate consumption, measured by interviewer-administered questionnaire or serum theobromine, a biomarker for cocoa, and risk of preeclampsia, and have showed somewhat conflicting results. A systematic review of observational and experimental studies will be carried out. We will examine PubMed, Embase, and the entire Cochrane Library. Studies of chocolate consumption compared or not with placebo or low flavanol chocolate during pregnancy will be evaluated to investigate the effect of chocolate consumption in pregnant women on the risk of preeclampsia or pregnancy-induced hypertension. Screening for inclusion, data extraction, and quality assessment will be performed independently by two reviewers in consultation with a third reviewer. Validity of the studies will be ascertained by using the Cochrane Collaboration's tool. Relative risk of preeclampsia will be the primary measure of treatment effect. Heterogeneity will be explored by subgroup analysis according to confounding factors and bias. This systematic review will contribute to establish the current state of knowledge concerning the possible association between chocolate consumption and prevention of preeclampsia. Furthermore, it will justify if additional experimental trials are necessary to better evaluate the benefits of chocolate consumption on the risk of preeclampsia.Trial registration: This systematic review has been registered in the PROSPERO international prospective register of systematic reviews. The registration number is: CRD42013005338.
Article
Full-text available
Background: Evidence from clinical studies has suggested that cocoa may increase high-density lipoprotein (HDL)-cholesterol concentrations. However, it is unclear whether this effect is attributable to flavonoids or theobromine, both of which are major cocoa components. Objectives: We investigated whether pure theobromine increases serum HDL cholesterol and whether there is an interaction effect between theobromine and cocoa. Design: The study had a 2-center, double-blind, randomized, placebo-controlled, full factorial parallel design. After a 2-wk run-in period, 152 healthy men and women (aged 40-70 y) were randomly allocated to consume one 200-mL drink/d for 4 wk that contained 1) cocoa, which naturally provided 150 mg theobromine and 325 mg flavonoids [cocoa intervention (CC)], 2) 850 mg pure theobromine [theobromine intervention (TB)], 3) cocoa and added theobromine, which provided 1000 mg theobromine and 325 mg flavonoids [theobromine and cocoa intervention (TB+CC)], or 4) neither cocoa nor theobromine (placebo). Blood lipids and apolipoproteins were measured at the start and end of interventions. Results: In a 2-factor analysis, there was a significant main effect of the TB (P < 0.0001) but not CC (P = 0.1288) on HDL cholesterol but no significant interaction (P = 0.3735). The TB increased HDL-cholesterol concentrations by 0.16 mmol/L (P < 0.0001). Furthermore, there was a significant main effect of the TB on increasing apolipoprotein A-I (P < 0.0001) and decreasing apolipoprotein B and LDL-cholesterol concentrations (P < 0.02). Conclusions: Theobromine independently increased serum HDL-cholesterol concentrations by 0.16 mmol/L. The lack of significant cocoa and interaction effects suggested that theobromine may be the main ingredient responsible for the HDL cholesterol-raising effect. This trial was registered at clinicaltrials.gov as NCT01481389.
Article
Background: Theobromine, a methylxanthine related to caffeine and present in high levels in cocoa, may contribute to the appeal of chocolate. However, current evidence for this is limited. Objectives: We conducted a within-subjects placebo-controlled study of a wide range of oral theobromine doses (250, 500, and 1,000 mg) using an active control dose of caffeine (200 mg) in 80 healthy participants. Results: Caffeine had the expected effects on mood including feelings of alertness and cardiovascular parameters. Theobromine responses differed according to dose; it showed limited subjective effects at 250 mg and negative mood effects at higher doses. It also dose-dependently increased heart rate. In secondary analyses, we also examined individual differences in the drug's effects in relation to genes related to their target receptors, but few associations were detected. Conclusions: This study represents the highest dose of theobromine studied in humans. We conclude that theobromine at normal intake ranges may contribute to the positive effects of chocolate, but at higher intakes, effects become negative.